4DMEDICAL Ltd (4DX) - Net Assets
Based on the latest financial reports, 4DMEDICAL Ltd (4DX) has net assets worth AU$-28.40 Million AUD (≈ $-20.10 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$139.55 Million ≈ $98.74 Million USD) and total liabilities (AU$167.95 Million ≈ $118.84 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read 4DMEDICAL Ltd total liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$-28.40 Million |
| % of Total Assets | -20.35% |
| Annual Growth Rate | 57.85% |
| 5-Year Change | -10.11% |
| 10-Year Change | -22.94% |
| Growth Volatility | 102.43 |
4DMEDICAL Ltd - Net Assets Trend (2014–2025)
This chart illustrates how 4DMEDICAL Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 4DX total asset value for the complete picture of this company's asset base.
Annual Net Assets for 4DMEDICAL Ltd (2014–2025)
The table below shows the annual net assets of 4DMEDICAL Ltd from 2014 to 2025. For live valuation and market cap data, see 4DX company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$64.24 Million ≈ $45.45 Million |
0.00% |
| 2024-12-31 | AU$64.24 Million ≈ $45.45 Million |
-9.43% |
| 2024-06-30 | AU$70.93 Million ≈ $50.19 Million |
0.00% |
| 2023-12-31 | AU$70.93 Million ≈ $50.19 Million |
-0.75% |
| 2023-06-30 | AU$71.46 Million ≈ $50.56 Million |
0.00% |
| 2022-12-31 | AU$71.46 Million ≈ $50.56 Million |
+20.08% |
| 2022-06-30 | AU$59.51 Million ≈ $42.11 Million |
0.00% |
| 2021-12-31 | AU$59.51 Million ≈ $42.11 Million |
-28.61% |
| 2021-06-30 | AU$83.36 Million ≈ $58.98 Million |
0.00% |
| 2020-12-31 | AU$83.36 Million ≈ $58.98 Million |
+805.82% |
| 2020-06-30 | AU$-11.81 Million ≈ $-8.36 Million |
0.00% |
| 2019-12-31 | AU$-11.81 Million ≈ $-8.36 Million |
-359.23% |
| 2019-06-30 | AU$4.56 Million ≈ $3.22 Million |
0.00% |
| 2018-12-31 | AU$4.56 Million ≈ $3.22 Million |
+20.58% |
| 2018-06-30 | AU$3.78 Million ≈ $2.67 Million |
0.00% |
| 2017-12-31 | AU$3.78 Million ≈ $2.67 Million |
+16.27% |
| 2017-06-30 | AU$3.25 Million ≈ $2.30 Million |
0.00% |
| 2016-12-31 | AU$3.25 Million ≈ $2.30 Million |
+250.68% |
| 2016-06-30 | AU$926.64K ≈ $655.66K |
0.00% |
| 2015-12-31 | AU$926.64K ≈ $655.66K |
+73.88% |
| 2015-06-30 | AU$532.93K ≈ $377.08K |
0.00% |
| 2014-12-31 | AU$532.93K ≈ $377.08K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to 4DMEDICAL Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 18115093000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$239.97 Million | 373.58% |
| Other Comprehensive Income | AU$6.37 Million | 9.92% |
| Total Equity | AU$64.24 Million | 100.00% |
4DMEDICAL Ltd Competitors by Market Cap
The table below lists competitors of 4DMEDICAL Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SJM HOLDINGS UNSP.ADR/4
F:3MG1
|
$1.66 Billion |
|
Hyundai Mar&Fi
KO:001450
|
$1.66 Billion |
|
Guangdong Yizumi Precision Machinery Co Ltd
SHE:300415
|
$1.66 Billion |
|
U-Ming Marine Transport Corp
TW:2606
|
$1.66 Billion |
|
West China Cement Limited
F:WFG1
|
$1.66 Billion |
|
Innoviva Inc
NASDAQ:INVA
|
$1.66 Billion |
|
SEAZEN GROUP LTD. HD-001
F:6FLA
|
$1.66 Billion |
|
Anupam Rasayan India Limited
NSE:ANURAS
|
$1.66 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in 4DMEDICAL Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 64,235,164 to 64,235,164, a change of 0 (0.0%).
- Net loss of 30,069,854 reduced equity.
- Share repurchases of 1,360,787 reduced equity.
- New share issuances of 14,703,355 increased equity.
- Other factors increased equity by 16,727,286.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-30.07 Million | -46.81% |
| Share Repurchases | AU$1.36 Million | -2.12% |
| Share Issuances | AU$14.70 Million | +22.89% |
| Other Changes | AU$16.73 Million | +26.04% |
| Total Change | AU$- | 0.00% |
Book Value vs Market Value Analysis
This analysis compares 4DMEDICAL Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 13.68x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.11x to 13.68x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | AU$35.79 | AU$4.09 | x |
| 2015-06-30 | AU$35.79 | AU$4.09 | x |
| 2015-12-31 | AU$37.70 | AU$4.09 | x |
| 2016-06-30 | AU$37.70 | AU$4.09 | x |
| 2016-12-31 | AU$0.02 | AU$4.09 | x |
| 2017-06-30 | AU$0.02 | AU$4.09 | x |
| 2017-12-31 | AU$0.02 | AU$4.09 | x |
| 2018-06-30 | AU$0.02 | AU$4.09 | x |
| 2018-12-31 | AU$0.03 | AU$4.09 | x |
| 2019-06-30 | AU$0.03 | AU$4.09 | x |
| 2019-12-31 | AU$-0.04 | AU$4.09 | x |
| 2020-06-30 | AU$-0.04 | AU$4.09 | x |
| 2020-12-31 | AU$0.32 | AU$4.09 | x |
| 2021-06-30 | AU$0.32 | AU$4.09 | x |
| 2021-12-31 | AU$0.20 | AU$4.09 | x |
| 2022-06-30 | AU$0.20 | AU$4.09 | x |
| 2022-12-31 | AU$0.24 | AU$4.09 | x |
| 2023-06-30 | AU$0.24 | AU$4.09 | x |
| 2023-12-31 | AU$0.22 | AU$4.09 | x |
| 2024-06-30 | AU$0.22 | AU$4.09 | x |
| 2024-12-31 | AU$0.30 | AU$4.09 | x |
| 2025-06-30 | AU$0.30 | AU$4.09 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently 4DMEDICAL Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -46.81%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -513.72%
- • Asset Turnover: 0.06x
- • Equity Multiplier: 1.48x
- Recent ROE (-46.81%) is above the historical average (-62.78%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -26.09% | -54.99% | 0.37x | 1.27x | AU$-192.32K |
| 2015 | -26.09% | -54.99% | 0.37x | 1.27x | AU$-192.32K |
| 2015 | -86.94% | -226.93% | 0.32x | 1.19x | AU$-887.86K |
| 2016 | -86.94% | -226.93% | 0.32x | 1.19x | AU$-887.86K |
| 2016 | -122.29% | -206438.29% | 0.00x | 1.52x | AU$-4.30 Million |
| 2017 | -122.29% | -206438.29% | 0.00x | 1.52x | AU$-4.30 Million |
| 2017 | -104.20% | -498.82% | 0.14x | 1.44x | AU$-4.31 Million |
| 2018 | -104.20% | -498.82% | 0.14x | 1.44x | AU$-4.31 Million |
| 2018 | -142.48% | -933.96% | 0.08x | 1.98x | AU$-6.95 Million |
| 2019 | -142.48% | -933.96% | 0.08x | 1.98x | AU$-6.95 Million |
| 2019 | 0.00% | -1782.99% | 0.08x | 0.00x | AU$-20.79 Million |
| 2020 | 0.00% | -1782.99% | 0.08x | 0.00x | AU$-20.79 Million |
| 2020 | -25.70% | -9872.21% | 0.00x | 1.11x | AU$-29.76 Million |
| 2021 | -25.70% | -9872.21% | 0.00x | 1.11x | AU$-29.76 Million |
| 2021 | -41.32% | -2332.63% | 0.01x | 1.25x | AU$-30.54 Million |
| 2022 | -41.32% | -2332.63% | 0.01x | 1.25x | AU$-30.54 Million |
| 2022 | -44.02% | -4378.04% | 0.01x | 1.30x | AU$-38.61 Million |
| 2023 | -44.02% | -4378.04% | 0.01x | 1.30x | AU$-38.61 Million |
| 2023 | -50.73% | -958.34% | 0.03x | 1.69x | AU$-43.07 Million |
| 2024 | -50.73% | -958.34% | 0.03x | 1.69x | AU$-43.07 Million |
| 2024 | -46.81% | -513.72% | 0.06x | 1.48x | AU$-36.49 Million |
| 2025 | -46.81% | -513.72% | 0.06x | 1.48x | AU$-36.49 Million |
Industry Comparison
This section compares 4DMEDICAL Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $170,916,465
- Average return on equity (ROE) among peers: -47.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| 4DMEDICAL Ltd (4DX) | AU$-28.40 Million | -26.09% | N/A | $1.66 Billion |
| Adherium Ltd (ADR) | $34.53 Million | -3.63% | 0.08x | $7.37 Million |
| Aroa Biosurgery Ltd (ARX) | $9.77 Million | 0.00% | 0.24x | $157.04 Million |
| Atomo Diagnostics Ltd (AT1) | $14.79 Million | -67.33% | 0.11x | $13.76 Million |
| Avita Medical Inc (AVH) | $5.12 Million | -224.74% | 0.50x | $127.84 Million |
| Anteris Technologies Global Corp (AVR) | $38.56 Million | -65.49% | 0.07x | $572.20 Million |
| Control Bionics Ltd (CBL) | $5.51 Million | -110.89% | 0.49x | $16.32 Million |
| Cardiex Ltd (CDX) | $4.88 Million | 56.04% | 0.31x | $13.23 Million |
| Compumedics Ltd (CMP) | $23.59 Million | 5.75% | 0.77x | $40.28 Million |
| Cochlear Ltd (COH) | $1.40 Billion | -17.00% | 0.84x | $4.64 Billion |
About 4DMEDICAL Ltd
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function im… Read more